[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MA41850A - Nouvelles utilisations pharmaceutiques - Google Patents

Nouvelles utilisations pharmaceutiques

Info

Publication number
MA41850A
MA41850A MA041850A MA41850A MA41850A MA 41850 A MA41850 A MA 41850A MA 041850 A MA041850 A MA 041850A MA 41850 A MA41850 A MA 41850A MA 41850 A MA41850 A MA 41850A
Authority
MA
Morocco
Prior art keywords
new pharmaceutical
pharmaceutical uses
new
pharmaceutical
Prior art date
Application number
MA041850A
Other languages
English (en)
Inventor
Mark Hibberd
Richard Jenkins
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55806738&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA41850(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB1505526.2A external-priority patent/GB201505526D0/en
Priority claimed from GBGB1521015.6A external-priority patent/GB201521015D0/en
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of MA41850A publication Critical patent/MA41850A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA041850A 2015-03-31 2016-03-29 Nouvelles utilisations pharmaceutiques MA41850A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1505526.2A GB201505526D0 (en) 2015-03-31 2015-03-31 Novel pharmaceutical uses
GBGB1521015.6A GB201521015D0 (en) 2015-11-27 2015-11-27 Novel pharmaceutical uses

Publications (1)

Publication Number Publication Date
MA41850A true MA41850A (fr) 2018-02-06

Family

ID=55806738

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041850A MA41850A (fr) 2015-03-31 2016-03-29 Nouvelles utilisations pharmaceutiques

Country Status (22)

Country Link
US (2) US20180085361A1 (fr)
EP (1) EP3277279A1 (fr)
JP (1) JP2018513140A (fr)
KR (1) KR20170132260A (fr)
CN (1) CN107530335A (fr)
AU (1) AU2016241069A1 (fr)
BR (1) BR112017021024A2 (fr)
CA (1) CA2981244A1 (fr)
CL (1) CL2017002325A1 (fr)
CO (1) CO2017010019A2 (fr)
CR (1) CR20170404A (fr)
DO (1) DOP2017000218A (fr)
EA (1) EA201792148A1 (fr)
EC (1) ECSP17072984A (fr)
IL (1) IL254419A0 (fr)
MA (1) MA41850A (fr)
MX (1) MX2017012414A (fr)
PE (1) PE20180195A1 (fr)
PH (1) PH12017501751A1 (fr)
SG (1) SG11201706739WA (fr)
TN (1) TN2017000416A1 (fr)
WO (1) WO2016159386A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107438610A (zh) 2015-03-31 2017-12-05 拜欧蒂姆公司 杂环化合物及它们在预防或治疗细菌感染中的应用
TWI838340B (zh) 2017-07-10 2024-04-11 日商武田藥品工業股份有限公司 含有沃諾拉贊的製劑
WO2024027549A1 (fr) * 2022-08-04 2024-02-08 江苏柯菲平医药股份有限公司 Composition pharmaceutique contenant un inhibiteur de sécrétion d'acide gastrique pyrrole et son procédé de préparation
CN116270443A (zh) * 2022-10-27 2023-06-23 广州白云山天心制药股份有限公司 富马酸伏诺拉生注射液及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1784404E (pt) 2004-09-03 2011-12-09 Yuhan Corp Derivados de pirrolo[2,3-c]piridina e processos para a sua preparação
WO2008130863A2 (fr) * 2007-04-11 2008-10-30 Auspex Pharmaceuticals, Inc. Benzimidazoles substitués
WO2010013823A2 (fr) 2008-07-28 2010-02-04 Takeda Pharmaceutical Company Limited Composition pharmaceutique
RU2586276C2 (ru) 2009-07-09 2016-06-10 Раквалиа Фарма Инк. Антагонист кислотного насоса для лечения заболеваний, связанных с патологическим нарушением моторики желудочно-кишечного тракта
CA2902624C (fr) 2013-02-28 2021-05-18 Takeda Pharmaceutical Company Limited Procede de production d'un compose de chlorure de sulfonyle
CN103951652B (zh) * 2014-04-18 2015-09-23 潍坊博创国际生物医药研究院 5-(2-氟苯基)-n-甲基-1-(3-吡啶基磺酰基)-1h-吡咯-3-甲胺水溶性有机酸盐和注射剂及它们的制备方法

Also Published As

Publication number Publication date
PE20180195A1 (es) 2018-01-26
KR20170132260A (ko) 2017-12-01
CR20170404A (es) 2018-01-10
AU2016241069A1 (en) 2017-09-21
SG11201706739WA (en) 2017-09-28
MX2017012414A (es) 2018-01-26
WO2016159386A1 (fr) 2016-10-06
ECSP17072984A (es) 2018-02-28
CN107530335A (zh) 2018-01-02
CA2981244A1 (fr) 2016-10-06
US20190070159A1 (en) 2019-03-07
DOP2017000218A (es) 2018-01-31
US20180085361A1 (en) 2018-03-29
PH12017501751A1 (en) 2018-04-11
CO2017010019A2 (es) 2018-02-20
EP3277279A1 (fr) 2018-02-07
TN2017000416A1 (en) 2019-01-16
JP2018513140A (ja) 2018-05-24
CL2017002325A1 (es) 2017-12-29
IL254419A0 (en) 2017-11-30
EA201792148A1 (ru) 2018-02-28
BR112017021024A2 (pt) 2018-07-03

Similar Documents

Publication Publication Date Title
DK3328880T3 (da) Terapeutiske midler
DK3323269T3 (da) Målingsbaseret direkte adgangskonfiguration
DK3297605T3 (da) Topiske, farmaceutiske sammesætninger
DK3587417T3 (da) 1,3-thiazol-2-yl-substituerede benzamider
DK3265421T3 (da) Doseringssystem
DK3188724T3 (da) Liposom-indkapslet affinitetsmedikament
BR112016023628A2 (pt) composições farmacêuticas.
MA50541A (fr) Formulations pharmaceutiques
DK3089741T3 (da) Farmaceutiske sammensætninger omfattende azd9291
DK3259015T3 (da) Bioelektroniske lægemidler
MA42303A (fr) Formulations pharmaceutiques
BR112017027227A2 (pt) Agente anti-câncer
DK3529240T3 (da) Farmaceutiske forbindelser
DK3283058T3 (da) Ribociclib-tablet
MA46867A (fr) Formulations pharmaceutiques
MA45187A (fr) Combinaisons pharmaceutiques
DK3223796T3 (da) Farmaceutiske sammensætninger, fremstilling og anvendelser deraf
MA49837A (fr) Compositions pharmaceutiques
DK3583943T3 (da) Farmaceutisk sammensætning
KR20180084810A (ko) 정제 세트
MA41022A (fr) Ciblage lysosomial et utilisations correspondantes
MA41850A (fr) Nouvelles utilisations pharmaceutiques
DK3280447T3 (da) Farmaceutiske formuleringer
FR3026399B1 (fr) Grue, notamment grue-derrick
DE112017002511A5 (de) Schaftfräser